Perrigo (PRGO) Capital Expenditures (2013 - 2026)
Perrigo (PRGO) reported Capital Expenditures of $13.8 million for Q1 2026, down 45.88% year-over-year from $25.5 million in Q1 2025, and down 48.51% quarter-over-quarter from $26.8 million in Q4 2025.
Perrigo (PRGO) Capital Expenditures (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Capital Expenditures data on file, last reported at $13.8 million in Q1 2026.
- Capital Expenditures for Q1 2026 came in at $13.8 million, down 45.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $81.7 million (down 31.17% YoY), and the FY2025 annual result was $93.4 million, down 21.05% from the prior year.
- Capital Expenditures retreated to $13.8 million in Q1 2026 per PRGO's latest filing, from $26.8 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $60.0 million in Q4 2022 and troughed at -$10.3 million in Q3 2022.
- A 5-year average of $24.9 million and a median of $25.5 million in 2025 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2022 and 2023: Capital Expenditures plunged 3533.33% in 2022, then soared 294.17% in 2023.
- A 5-year view of Capital Expenditures shows it stood at $26.4 million in 2022, then gained by 1.14% to $26.7 million in 2023, then surged by 41.2% to $37.7 million in 2024, then decreased by 28.91% to $26.8 million in 2025, then slumped by 48.51% to $13.8 million in 2026.
- Business Quant data shows PRGO's Capital Expenditures at $13.8 million in Q1 2026, $26.8 million in Q4 2025, and $21.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 168.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 110.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 100.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 9.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 51.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 4.09 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 2.04 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 8.83 Mn |
| 10 | Perrigo | 1.61 Bn | 1.25 Bn | 325.50 Mn | 13.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 13.80 Mn |
| Mar 28, 2026 | 13.80 Mn |
| Dec 31, 2025 | 26.80 Mn |
| Dec 31, 2025 | 26.80 Mn |
| Sep 27, 2025 | 21.90 Mn |
| Sep 27, 2025 | 21.90 Mn |
| Jun 28, 2025 | 19.20 Mn |
| Jun 28, 2025 | 19.20 Mn |
| Mar 29, 2025 | 25.50 Mn |
| Mar 29, 2025 | 25.50 Mn |
| Dec 31, 2024 | 37.70 Mn |
| Dec 31, 2024 | 37.70 Mn |
| Sep 28, 2024 | 27.10 Mn |
| Sep 28, 2024 | 27.10 Mn |
| Jun 29, 2024 | 28.40 Mn |
| Jun 29, 2024 | 28.40 Mn |
| Mar 30, 2024 | 25.10 Mn |
| Mar 30, 2024 | 25.10 Mn |
| Dec 31, 2023 | 26.70 Mn |
| Dec 31, 2023 | 26.70 Mn |